Syteca 7.21 is live — Real-time data masking, agentless access & more
Every Interaction Secured
Every Action Visible
Real-time data masking, agentless access, modern design, and beyond.
Get inspired by how Syteca’s extensive capabilities can cover your use case.
Download “How to build Insider Threat Program in 10 Steps” white paper and enhance your insider risk management strategy through concrete actions.
Assist your customers in building secure and reliable IT infrastructures
Case Study
Industry
Logistics
Location
Israel
The Maman Group is an organization based in Israel that excels in logistics and aviation services. They provide comprehensive solutions to businesses and airlines. From cargo management and ground-handling services to supply chain management and third-party logistics. Company stands as a leader in their respective fields, delivering excellence and efficiency in every aspect of their operations. The Maman Group has made the decision to enhance and fortify their data security posture.
Maman Group, a logistics company providing cargo management and ground handling services for airlines, decided to strengthen their data security posture. To accomplish this goal, they defined several objectives.
To reach these objectives, they decided to deploy a dedicated solution. After examining several market offerings, Maman Group decided to go with Syteca.
In addition to Syteca, we’ve examined other system solutions, but after comparing the different systems’ features and capabilities, the conclusion was very clear that Syteca provides the most diverse and extensive platform and set of capabilities.
Yoav Geffen
Chief Information Security Officer at Maman Group
With the help of Syteca’s powerful features, Maman Group managed to:
We definitely achieved the goal we set out for ourselves. The Syteca gave us all the capabilities we wished for, and so much more. It contributed a great deal and maximized Maman Group’s data security.
See how Syteca enabled the customer’s success
Share:
Start doing it today by requesting the Syteca trial.